<DOC>
	<DOCNO>NCT02400398</DOCNO>
	<brief_summary>Eligible patient diagnosis pancreatic adenocarcinoma cachexia define great 5 % unintentional weight loss within 6 month prior screen visit . Patients must great 18 year age ; great 3 month life expectancy . This study observe standard care intervention ( tube feed ) potential benefit . Peptamen administer jejunal gastrojejunal feeding tube dose calculate use Mifflin St. Jeor equation . It administer daily duration protocol .</brief_summary>
	<brief_title>Evaluating Weight Stability Pancreatic Cancer Cachexia Patients</brief_title>
	<detailed_description>In study , prospectively evaluate advanced pancreatic adenocarcinoma patient cachexia , receive enteral feeding , peptide base diet ( medical food ) , jejunal gastrojejunal feeding tube . We plan collect serum sample routinely establish cohort patient clinical syndrome . Our aim establish feasibility efficacy enteral nutrition relationship meaningful clinical outcome . Furthermore , assess correlation cachexia , activity , patient report outcome domain quality life optional activity tracker sub-study .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>Advanced locally advance pancreatic cancer patient ( include new recurrent diagnosis ) refer SOCCICSMC chemotherapy Cachexia define great 5 % unexplained weight loss within 6 month prior screen visit consultation medical oncologist Candidate enteral feed Peptamen , peptide base formula . Must jejunal gastrojejunal tube either previously place least prior Day 1 study ECOG performance status 02 Greater equal 3 month life expectancy Ability understand willingness sign write informed consent May receive prior anticancer treatment , complete partial resection primary tumor Patients must ambulatory access smart phone participate activity tracker substudy Patients know brain metastasis exclude clinical trial poor prognosis often develop progressive neurologic dysfunction would confound evaluation neurologic adverse event Malignant ascites require paracenteses Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Bowel obstruction , partial total Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>